Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 3/20 | 0.66 |
| ▸ | MTNR1B | P49286 | 3/20 | 0.66 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.66 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.66 |
| ▸ | HPGD | P15428 | 2/20 | 0.66 |
| ▸ | TSHR | P16473 | 2/20 | 0.66 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.66 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.66 |
| ▸ | MEN1 | O00255 | 2/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.66 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.62 |
| ▸ | MAPT | P10636 | 2/20 | 0.61 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.61 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.61 |
| ▸ | EGFR | P00533 | 5/20 | 0.61 |
| ▸ | SRC | P12931 | 4/20 | 0.61 |
| ▸ | GPR17 | Q13304 | 1/20 | 0.55 |
| ▸ | MC4R | P32245 | 3/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8001497 | 0.92 | MTNR1A (0.63) | MTNR1AMTNR1BCYP1A2CYP3A4HPGD | |
| SCHEMBL2087168 | 0.85 | HPGD (0.61) | MTNR1AMTNR1BCYP1A2CYP3A4HPGD | |
| SCHEMBL27348910 | 0.81 | EGFR (0.63) | MTNR1AMTNR1BCYP1A2CYP3A4HPGD | |
| SCHEMBL31034424 | 0.81 | HPGD (0.58) | MTNR1AMTNR1BCYP1A2CYP3A4HPGD | |
| SCHEMBL8804026 | 0.80 | MTNR1A (0.59) | MTNR1AMTNR1BCYP1A2CYP3A4HPGD | |
| SCHEMBL6862346 | 0.80 | KDM4E (0.63) | MTNR1AMTNR1BCYP1A2CYP3A4HPGD | |
| SCHEMBL30479097 | 0.80 | KDM4E (0.63) | MTNR1AMTNR1BCYP1A2CYP3A4HPGD | |
| Luzindole SCHEMBL4869000 | 0.80 | MTNR1A (1.00) | MTNR1AMTNR1BCYP1A2CYP3A4HPGD | |
| SCHEMBL18919603 | 0.80 | TSHR (0.58) | MTNR1AMTNR1BCYP1A2CYP3A4HPGD | |
| SCHEMBL29127032 | 0.79 | ALDH1A1 (0.58) | MTNR1AMTNR1BCYP1A2CYP3A4HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2000029022-A1 | COX-2 INHIBITORS IN COMBINATION WITH CENTRALLY ACTING ANALGESICS | ALGOS PHARMACEUTICAL CORPORATION (US) | 2000-05-25 | — | — | WO | claimed |
| WO-2016164593-A1 | COMPOSITIONS AND METHODS FOR MODULATING HYDROXYLATION OF ACC2 BY PHD3 | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2016-10-13 | — | — | WO | disclosed |
| EP-2147315-A2 | DIABETES-RELATED BIOMARKERS AND METHODS OF USE THEREOF | Tethys Bioscience, Inc. (US) | 2010-01-27 | — | — | EP | disclosed |
| EP-2001496-A4 | USE OF GELSOLIN TO DIAGNOSE AND TREAT INFLAMMATORY DISEASES | BRIGHAM & WOMENS HOSPITAL (US) | 2009-07-08 | — | — | EP | disclosed |
| EP-2001496-A2 | USE OF GELSOLIN TO DIAGNOSE AND TREAT INFLAMMATORY DISEASES | The Brigham & Women's Hospital, Inc. (US) | 2008-12-17 | — | — | EP | disclosed |
| WO-2008131224-A2 | DIABETES-RELATED BIOMARKERS AND METHODS OF USE THEREOF | TETHYS BIOSCIENCE, INC. (US) | 2008-10-30 | — | — | WO | disclosed |
| WO-2008048607-A2 | COLLAGEN PEPTIDES AS IMMUNE MODULATORS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2008-04-24 | — | — | WO | disclosed |
| WO-2007136674-A9 | DETECTION AND MONITORING OF LIVER DAMAGE | CLEVELAND CLINIC FOUNDATION (US) | 2008-02-21 | — | — | WO | disclosed |
| WO-2007136674-A1 | DETECTION AND MONITORING OF LIVER DAMAGE | THE CLEVELAND CLINIC FOUNDATION (US) | 2007-11-29 | — | — | WO | disclosed |
| WO-2007109056-A2 | USE OF GELSOLIN TO DIAGNOSE AND TREAT INFLAMMATORY DISEASES | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2007-09-27 | — | — | WO | disclosed |
| EP-1191929-A4 | (Z)-STYRYL ACETOXYPHENYL SULFIDES AS CYCLOOXYGENASE INHIBITORS | UNIV TEMPLE (US) | 2005-02-16 | — | — | EP | disclosed |
| EP-1451577-A2 | SOLUBLE CD40L(CD154) AS A PROGNOSTIC MARKER OF ATHEROSCLEROTIC DISEASES | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2004-09-01 | — | — | EP | disclosed |
| WO-2003040691-A2 | SOLUBLE CD40L(CD154) AS A PROGNOSTIC MARKER OF ATHEROSCLEROTIC DISEASES | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2003-05-15 | — | — | WO | disclosed |
| EP-1191931-A4 | 1-(4-SULFAMYLARYL)-3-SUBSTITUTED-5-ARYL-2-PYRAZOLINES AS INHIBITORS OF CYCLOOXYGENASE-2 | UNIV TEMPLE (US) | 2002-11-27 | — | — | EP | disclosed |
| EP-1191931-A1 | 1-(4-SULFAMYLARYL)-3-SUBSTITUTED-5-ARYL-2-PYRAZOLINES AS INHIBITORS OF CYCLOOXYGENASE-2 | Temple University of the Commonwealth System of Higher Education (US) | 2002-04-03 | — | — | EP | disclosed |
| EP-1191929-A2 | (Z)-STYRYL ACETOXYPHENYL SULFIDES AS CYCLOOXYGENASE INHIBITORS | Temple University of the Commonwealth System of Higher Education (US) | 2002-04-03 | — | — | EP | disclosed |
| WO-2000077169-A2 | (Z)-STYRYL ACETOXYPHENYL SULFIDES AS CYCLOOXYGENASE INHIBITORS | TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2000-12-21 | — | — | WO | disclosed |
| WO-2000076503-A1 | 1-(4-SULFAMYLARYL)-3-SUBSTITUTED-5-ARYL-2-PYRAZOLINES AS INHIBITORS OF CYCLOOXYGENASE-2 | TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2000-12-21 | — | — | WO | disclosed |
| WO-2000076983-A1 | 1-(4-ARYLSULFONYL)-3-SUBSTITUTED-5-ARYL-2-PYRAZOLINES AS INHIBITORS OF CYCLOOXYGENASE-2 | TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2000-12-21 | — | — | WO | disclosed |
| EP-0804416-A1 | HETEROCYCLIC COMPOUNDS, USEFUL AS ALLOSTERIC EFFECTORS AT MUSCARINIC RECEPTORS | SANKYO COMPANY LIMITED (JP) | 1997-11-05 | — | — | EP | disclosed |